title: Histological inflammation in Crohn's disease in deep remission during treatment with anti-TNFα.
authors.affiliation: Gastroenterology Service, ASL BAT, Andria, BT, Italy. Electronic address: antotursi@tiscali.it.
authors.forename: Antonio
authors.initials: A
authors.lastname: Tursi
authors.affiliation: Division of Gastroenterology, ASL RMH, Albano Laziale, Roma, Italy.
authors.forename: Walter
authors.initials: W
authors.lastname: Elisei
authors.affiliation: Division of Surgery, "P. Colombo" Hospital, ASL RMH, Velletri, Roma, Italy.
authors.forename: Marcello
authors.initials: M
authors.lastname: Picchio
authors.affiliation: Division of Gastroenterology, "Cristo Re" Hospital, Roma, Italy.
authors.forename: Giovanni
authors.initials: G
authors.lastname: Brandimarte
mesh_terms: D000068879:Adalimumab; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use; D001706:Biopsy; D003092:Colitis / Q000473:pathology*; D003424:Crohn Disease / Q000188:drug therapy / Q000473:pathology*; D006801:Humans; D007079:Ileitis / Q000473:pathology*; D000069285:Infliximab; D007413:Intestinal Mucosa / Q000473:pathology*; D012074:Remission Induction; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab; D000068879:Adalimumab